KOREA PHARMA Co., Ltd. (KOSDAQ:032300)
South Korea · Delayed Price · Currency is KRW 13,900
0.00 (0.00%)
At close: Dec 5, 2025
KOREA PHARMA Market Cap
KOREA PHARMA has a market cap or net worth of 151.6 billion as of December 5, 2025. Its market cap has decreased by -22.56% in one year.
Market Cap
151.60B
Enterprise Value
156.41B
Revenue
90.11B
Ranking
n/a
PE Ratio
870.51
Stock Price
13,900.00
Market Cap Chart
Since August 10, 2020, KOREA PHARMA's market cap has decreased from 183.78B to 151.60B, a decrease of -17.51%. That is a compound annual growth rate of -3.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 151.60B | -9.21% |
| Dec 30, 2024 | 166.98B | -35.26% |
| Dec 28, 2023 | 257.94B | 10.51% |
| Dec 29, 2022 | 233.40B | -55.92% |
| Dec 30, 2021 | 529.52B | 118.69% |
| Dec 30, 2020 | 242.13B | 31.75% |
| Aug 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 684.69T |
| SK hynix | 381.13T |
| LG Energy Solution | 97.81T |
| Samsung Biologics | 76.57T |
| Hyundai Motor Company | 58.03T |
| Doosan Enerbility | 50.21T |
| KB Financial Group | 47.58T |
| HD Hyundai Heavy Industries | 47.40T |